IU Health
Anita A. Turk, MD - Hematology - Oncology
Get to know me

Anita A. Turk, MD

IU Health

Hematology - Oncology

4.8 out of 5 stars (108 ratings)
Accepting New Patients
Call to Schedule

Already a Patient? Connect on My IU Health

Phone
Fax
  • Biography
  • Insurance
  • Locations
  • Specialties & Details
  • Ratings & Reviews
  • Clinical Trials
  • Related Stories
Biography

Dr. Anita Turk is a board-certified oncologist who specializes in gastrointestinal cancers including:

Research

Dr. Turk focuses her research in identifying and developing new therapy options for patients with cholangiocarcinoma (bile duct cancer) and pancreatic cancer.

Personal

Outside of practicing medicine, Dr. Turk enjoys reading and traveling.

Insurance

Insurance plans accepted by this provider are below.

  • Aetna Medicare Advantage
American Health Plan of Indiana/Majestic Care Management I-SNP
  • Anthem Blue Cross Blue Shield
  • Anthem Healthy Indiana Plan
  • Anthem Hoosier Care Connect
  • Anthem Hoosier Healthwise
  • Anthem Indiana PathWays for Aging
  • Anthem Medicare Advantage HMO
  • Anthem Medicare Advantage PPO
  • Anthem Pathway Essentials Network
  • CareSource Healthy Indiana Plan
  • CareSource Hoosier Healthwise
  • Cigna Marketplace
Community Health Alliance
Community Health Network Employee Plan
Coventry/First Health
Deaconess OneCare
  • Encore Combined
  • Encore Elite
  • Encore Workers Compensation
  • Humana Healthy Horizons Indiana PathWays for Aging
  • Humana Medicare Advantage HMO
  • Humana Medicare Advantage PFFS
  • Humana Medicare Advantage PPO
Indiana University Health Workers Compensation
Indiana University Workers Compensation
Lutheran Preferred/Three Rivers Preferred
  • Managed Health Services Healthy Indiana Plan
  • Managed Health Services Hoosier Care Connect
  • Managed Health Services Hoosier Healthwise
  • Managed Health Services Marketplace
  • Managed Health Services Medicare Advantage (Allwell)
MultiPlan/PHCS
NaphCare
Parkview Signature Care PPO (Excludes Allen County)
Physicians Health Plan of Northern Indiana (PHP) (Allen County)
Point Comfort Unaccompanied Children Program
Provider Partners Health Plan (PPHP) I-SNP
Sagamore Health Network
Select Health
SIHO
Suburban Health Organization (SHO)
  • UnitedHealthcare Community Plan Indiana PathWays for Aging
  • UnitedHealthcare Hoosier Care Connect
  • UnitedHealthcare Marketplace
  • UnitedHealthcare Medicare Advantage D-SNP
  • UnitedHealthcare Medicare Advantage HMO
  • UnitedHealthcare Medicare Advantage PPO
VA Community Care Network
  • Zing Health Medicare Advantage C-SNP
  • Zing Health Medicare Advantage D-SNP
  • Zing Health Medicare Advantage HMO
  • Zing Health Medicare Advantage POS
  • Zing Health Medicare Advantage PPO

Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.

Locations
Specialties & Details

Specialties:

Hematology - Oncology

Conditions & Treatments:

Gastrointestinal Cancer, Anal Cancer, Colon Cancer, Gallbladder Cancer, Liver Cancer, Pancreatic Cancer

Education

School of Medicine:

Indiana University School of Medicine; Indianapolis, IN

Residency:

University Of Chicago; Chicago, IL

Fellowship:

University of Wisconsin Hospitals and Clinics; Madison, WI

Hospitals & Affiliations

Hospital Privileges:

IU Health Methodist/IU Health University, IU Health North, IU Health West

Physician Group:

IU Health Medical Group

Research

Research Publications
* Information provided by PubMed

Related Services

Ratings & Reviews

Overall Provider Rating

Clinical Trials

Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.

Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations

View Details

A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiationfor the Treatment of Early-Stage Anal Cancer

View Details

A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of Tng462 in Combination with Other Agents in Patients with Pancreatic or Non-Small Cell Lung Cancer with Mtap Loss and Ras Mutation

View Details
Search All Clinical Trials
Related Stories
Patient Stories

She’s using her experience to give back to others

IU Health Simon Cancer Center — She’s undergoing chemotherapy and finding ways to ...
Read More
Patient Stories

Teacher diagnosed with liver, bile duct cancer: Friends are ‘Angela’s Army’

IU Health Simon Cancer Center — She felt a lump and pain in her abdomen that would...
Read More